Renaissance BioScience secures Australian patent for yeast-based RNA technology

Renaissance BioScience, a Canadian yeast bioengineering company, has been granted an Australian patent for its yeast-based RNA production and delivery platform, expanding its intellectual property portfolio in a field with growing industrial and agricultural demand.

The patent marks the second approval for the technology, following an earlier award in China, with additional applications pending in other jurisdictions. The platform is designed to produce RNA at low cost and deliver it effectively, addressing long-standing challenges of high production costs and molecular fragility that have limited RNA’s use in broader industries.

The company’s most advanced commercial application of the platform is a line of RNAi-based biopesticides aimed at providing targeted pest control. Unlike conventional chemical pesticides, these products are designed to offer environmental safety while maintaining comparable production economics at scale. The technology is compatible with existing agricultural practices and equipment, a factor Renaissance says could ease adoption by growers.

Australia, one of the world’s largest and most innovative agricultural economies, represents a strategic market for the rollout of RNAi biopesticides. Renaissance said the patent comes at a time when demand is rising for alternatives to chemical pest control methods that can reduce environmental impact without raising costs for farmers.

Beyond agriculture, the company sees applications for its RNA platform in animal health and human medicine, sectors it identified as “multi-billion-dollar” opportunities.

Vancouver-based Renaissance has built a portfolio of issued and pending patents across multiple industries, positioning itself as a developer of functional microorganisms for applications ranging from agriculture and health to food, beverage, and energy.